drug

ceftaroline fosamil

Marketedupdated 2mo ago

by Apotex Corp

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Sep 21, 2030

~4.2 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (4)

Feb 10, 2031formulationUS 82474004.6y
Feb 10, 2031formulationUS 82474004.6y
Sep 21, 2030formulationUS 96298614.2y
Sep 21, 2030formulationUS 96298614.2y

Trials studying ceftaroline fosamil

—Retrospective Chart Review Study to Assess Characteristics, Treatment Outcomes and Resource Use of Adults Hospitalized for CAP and CSSTi Treated With Zinforo in Multiple Countriescompletedn=317